What is the recommended treatment for eczema affecting the left cheek?

Treatment for Eczema on the Left Cheek

Start with a mid-potency topical corticosteroid applied once daily to the affected cheek, combined with regular moisturizer use to all facial areas, as this represents the evidence-based first-line approach for facial atopic dermatitis. 1, 2

Initial Treatment Strategy

The location on the face requires careful consideration due to the sensitive nature of facial skin and higher risk of skin atrophy with corticosteroids 3. Here's the algorithmic approach:

Step 1: Acute Phase (Gaining Control)

• Apply a mid-potency topical corticosteroid once daily to the eczematous area on the left cheek
  • Once-daily application is as effective as twice-daily use 4
  • Continue until the acute inflammation resolves (typically 2-4 weeks)
• Moisturize liberally to all facial areas, not just the affected cheek 1, 2
  • This addresses the underlying epidermal barrier dysfunction
  • Should be integral to the treatment plan given low risk and proven benefit

Step 2: Maintenance Phase (Preventing Flares)

Once acute inflammation is controlled, transition to proactive therapy rather than waiting for new flares:

• Apply the topical corticosteroid twice weekly to the previously affected area on the left cheek 1
  • This reduces flare risk by 54% (relative risk 0.46) compared to no maintenance treatment 1
  • Continue for 16-20 weeks or longer as needed
  • This approach is superior to reactive treatment (only treating when flares occur)

Alternative maintenance option: If concerned about corticosteroid use on facial skin, switch to a topical calcineurin inhibitor (tacrolimus 0.03% or 0.1%) applied 2-3 times weekly to the previously affected area 1, 5

• Reduces flare risk by 22% (relative risk 0.78) 1
• No risk of skin atrophy, making it particularly suitable for facial use 3, 6
• Meta-analysis suggests fluticasone may be slightly more effective than tacrolimus for flare prevention, but tacrolimus avoids atrophy concerns 1

Important Considerations for Facial Eczema

Facial skin requires special attention:

• The face is more prone to corticosteroid-induced atrophy 3
• For pediatric patients, use 0.03% tacrolimus; for adults, 0.1% tacrolimus 3
• Newer options include topical JAK inhibitors (delgocitinib) and PDE4 inhibitors (difamilast, crisaborole) as alternatives 5, 2

If standard treatment fails after 3-4 weeks:

• Consider adding 0.03% tacrolimus ointment as the primary topical agent for facial use 3
• For truly refractory cases, one case report showed complete resolution within 3 weeks using tacrolimus combined with oral tranilast (200 mg/day) and roxithromycin (300 mg/day) 3

Common Pitfalls to Avoid

• Don't apply corticosteroids only when flares occur - this reactive approach leads to more frequent relapses compared to scheduled maintenance therapy 1
• Don't use high-potency corticosteroids on the face - stick to mid-potency to minimize atrophy risk
• Don't stop moisturizers during maintenance - continue liberal moisturizer use even when using anti-inflammatory agents 1
• Don't assume infection without clear signs - empiric antibiotics for uninfected lesions are controversial; reserve for overt secondary infection 6

When to Escalate Treatment

If the facial eczema remains moderate-to-severe despite optimal topical therapy, consider systemic options 5, 2, 7:

• Biologics (dupilumab, tralokinumab, nemolizumab)
• JAK inhibitors (baricitinib, upadacitinib, abrocitinib)
• Conventional immunosuppressants (cyclosporine, methotrexate)

The evidence consistently shows that proactive maintenance with scheduled topical anti-inflammatory therapy is superior to reactive treatment, with the choice between corticosteroids and calcineurin inhibitors depending on atrophy concerns and patient preference 1.